NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

NCT01386619 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic Syndromes
Lymphoma
Neuroblastoma
Rhabdomyosarcoma

Interventions

BIOLOGICAL: CD3-depleted/CD56+ selected natural killer cells collected from apheresis products

Sponsor

University Hospital, Basel, Switzerland